AC Immune SA (ACIU)
NASDAQ: ACIU · IEX Real-Time Price · USD
3.480
-0.150 (-4.13%)
At close: Jul 19, 2024, 4:00 PM
3.500
+0.020 (0.57%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

AC Immune Revenue

AC Immune had revenue of $16.82M in the twelve months ending March 31, 2024, with 288.96% growth year-over-year. In the year 2023, AC Immune had annual revenue of $17.62M with 316.44% growth.

Revenue (ttm)
$16.82M
Revenue Growth
+288.96%
P/S Ratio
20.52
Revenue / Employee
$104,468
Employees
161
Market Cap
345.21M USD

Revenue Chart

* The company reports in CHF currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202317.62M13.39M316.44%
Dec 31, 20224.23M--
Dec 31, 20210--
Dec 31, 202017.54M-96.34M-84.60%
Dec 31, 2019113.87M106.82M1,514.51%
Dec 31, 20187.05M-13.73M-66.06%
Dec 31, 201720.78M-4.01M-16.16%
Dec 31, 201624.79M-14.36M-36.67%
Dec 31, 201539.14M8.67M28.46%
Dec 31, 201430.47M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ModivCare 2.78B
Nevro 430.75M
Vanda Pharmaceuticals 177.60M
Xeris Biopharma Holdings 171.36M
Talkspace 162.13M
Kamada 149.55M
ADC Therapeutics 68.62M
Cartesian Therapeutics 25.91M
Revenue Rankings